Literature DB >> 18465401

High-frequency ultrasonic atomization for drug delivery to rodent animal models - optimal particle size for lung inhalation of difluoromethyl ornithine.

Guifang Zhang1, Chris Fandrey, Amir Naqwi, Timothy Scott Wiedmann.   

Abstract

A high-(8-MHz) and a low-(1.7-MHz) frequency ultrasonic transducer were compared for delivering aerosols to mouse lung. The aerosol concentration (mass of dry particles/volume of air) rose nonlinearly with solution concentration of difluoromethyl ornithine for both transducers. The particle size was linear with the cube root of the solution concentration, and the slope of the low-frequency transducer was 8 times greater than that of the high-frequency transducer. The deposition fraction assessed by the assayed mass in the lung relative to the calculated inhaled mass was found to decline exponentially with particle size. The lower-frequency transducer provided a higher dose despite a lower deposition fraction, but the high-frequency transducer was more efficient and provides a more selective deposition in the lower respiratory tract while operating with significantly less demands on aerosol drying.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465401      PMCID: PMC5224704          DOI: 10.1080/01902140802022484

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  11 in total

1.  Analysis of a diffusion dryer for the respiratory delivery of poorly water soluble drugs.

Authors:  S Pham; T S Wiedmann
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  Measurement of the respiratory volumes of laboratory animals.

Authors:  A C GUYTON
Journal:  Am J Physiol       Date:  1947-07-01

3.  The fundamentals of the ultrasonic atomization of medicated solutions.

Authors:  R M Boucher; J Kreuter
Journal:  Ann Allergy       Date:  1968-11

4.  Some factors associated with the ultrasonic nebulization of proteins.

Authors:  R W Niven; A Y Ip; S Mittelman; S J Prestrelski; T Arakawa
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

5.  Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.

Authors:  O N McCallion; K M Taylor; M Thomas; A J Taylor
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

Review 6.  Development of inhalational agents for oncologic use.

Authors:  S Sharma; D White; A R Imondi; M E Placke; D M Vail; M G Kris
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

7.  Lung distribution of the chemopreventive agent difluoromethylornithine (DFMO) following oral and inhalation delivery.

Authors:  Xiangmin Liao; Wei Liang; Timothy Wiedmann; Lee Wattenberg; Alan Dahl
Journal:  Exp Lung Res       Date:  2004-12       Impact factor: 2.459

8.  Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs.

Authors:  Venkatareddy Nadithe; Muhib Rahamatalla; Warren H Finlay; John R Mercer; John Samuel
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

9.  Chemoprevention of cancer of the upper respiratory tract of the Syrian golden hamster by aerosol administration of difluoromethylornithine and 5-fluorouracil.

Authors:  Lee W Wattenberg; Timothy S Wiedmann; Richard D Estensen
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

10.  High-pressure liquid chromatographic analysis of eflornithine in serum.

Authors:  J L Cohen; R J Ko; A T Lo; M D Shields; T M Gilman
Journal:  J Pharm Sci       Date:  1989-02       Impact factor: 3.534

View more
  1 in total

1.  Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.

Authors:  Tanmoy Sadhukha; Timothy S Wiedmann; Jayanth Panyam
Journal:  Biomaterials       Date:  2013-04-13       Impact factor: 12.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.